Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Metadata
Title
Prohibitin: a potential biomarker for tissue-based detection of gastric cancer
Authors
Xiangdong Kang
Long Zhang
Jian Sun
Zhenhua Ni
Yanchun Ma
Xiaobo Chen
Xia Sheng
Teng Chen
Publication date
01-08-2008
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 8/2008
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-008-2208-3

Other articles of this Issue 8/2008

Journal of Gastroenterology 8/2008 Go to the issue

OriginalPaper

Morphogenesis of a colorectal neoplasm with a type IIIS pit pattern inferred from isolated crypts

OriginalPaper

Long-term effects of lipase inhibition by orlistat on gastric emptying and orocecal transit time of a solid meal

OriginalPaper

Phenotypic alteration of interstitial cells of Cajal in idiopathic sigmoid megacolon

Review

Low-dose aspirin-induced gastrointestinal diseases: past, present, and future

Case Report

Temporary endosonography-guided biliary drainage for transgastrointestinal deployment of a self-expandable metallic stent

OriginalPaper

Impaired autonomic function in type 2 diabetic patients during upper gastrointestinal endoscopy

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits